Exploring Controversies Surrounding First-Line Therapy for Metastatic Urothelial Cancer

Default Digital Object Group ◽

10.1200/adn.21.200754 ◽

2021 ◽

Keyword(s):

Urothelial Cancer ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Cancer

Download Full-text

Overall Survival In Patients With Metastatic Urothelial Cancer By First-Line Therapy

Value in Health ◽

10.1016/j.jval.2017.08.137 ◽

2017 ◽

Vol 20 (9) ◽

pp. A421

Author(s):

NS Vander Velde ◽

A Guerin ◽

R Ionescu-Ittu ◽

S Shi ◽

E Wu ◽

...

Keyword(s):

Overall Survival ◽

Urothelial Cancer ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Cancer

Download Full-text

Options in metastatic urothelial cancer after first-line therapy

Current Opinion in Supportive and Palliative Care ◽

10.1097/spc.0000000000000158 ◽

2015 ◽

Vol 9 (3) ◽

pp. 255-260 ◽

Author(s):

Nimira S. Alimohamed ◽

Srikala S. Sridhar

Keyword(s):

Urothelial Cancer ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Cancer

Download Full-text

KEYNOTE-052: Phase 2 study of pembrolizumab (MK-3475) as first-line therapy for patients (pts) with unresectable or metastatic urothelial cancer ineligible for cisplatin-based therapy.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps4572 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS4572-TPS4572 ◽

Author(s):

Dean F. Bajorin ◽

Elizabeth R. Plimack ◽

Arlene O. Siefker-Radtke ◽

Toni K. Choueiri ◽

Ronald De Wit ◽

...

Keyword(s):

Urothelial Cancer ◽

Phase 2 ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Cancer ◽

Download Full-text

The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis

European Urology ◽

10.1016/j.eururo.2015.09.051 ◽

2016 ◽

Vol 69 (4) ◽

pp. 624-633 ◽

Author(s):

Patrizia Giannatempo ◽

Gregory R. Pond ◽

Guru Sonpavde ◽

Daniele Raggi ◽

Gurudatta Naik ◽

...

Keyword(s):

Systematic Review ◽

Urothelial Cancer ◽

Meta Analysis ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Cancer ◽

Platinum Chemotherapy ◽

Download Full-text

Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial Cancer

Advances in Therapy ◽

10.1007/s12325-021-01785-9 ◽

2021 ◽

Author(s):

Shuxia Qin ◽

Lidan Yi ◽

Sini Li ◽

Chongqing Tan ◽

Xiaohui Zeng ◽

...

Keyword(s):

Cost Effectiveness ◽

Urothelial Cancer ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Cancer

Download Full-text

PCN339 - SPEAR-BLADDER (STUDY INFORMING TREATMENT PATHWAY DECISION IN BLADDER CANCER): TIMING OF TREATMENT FOLLOWING FIRST-LINE THERAPY IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC UROTHELIAL CANCER IN THE COMMUNITY ONCOLOGY SETTING IN THE UNITED STATES

Value in Health ◽

10.1016/j.jval.2018.09.421 ◽

2018 ◽

Vol 21 ◽

pp. S72

Author(s):

G. Doshi ◽

A. Bhanegaonkar ◽

M. Bharmal ◽

H. Phatak ◽

M. Boyd ◽

...

Keyword(s):

Bladder Cancer ◽

Urothelial Cancer ◽

Locally Advanced ◽

The United States ◽

Treatment Pathway ◽

First Line Therapy ◽

Line Therapy ◽

Community Oncology ◽

Metastatic Urothelial Cancer

Download Full-text

Pembrolizumab (pembro) as first-line therapy for advanced/unresectable or metastatic urothelial cancer: Preliminary results from the phase 2 KEYNOTE-052 study

Annals of Oncology ◽

10.1093/annonc/mdw435.25 ◽

2016 ◽

Vol 27 ◽

pp. vi567 ◽

Author(s):

A. Balar ◽

J. Bellmunt ◽

P.H. O'Donnell ◽

D. Castellano ◽

P. Grivas ◽

...

Keyword(s):

Urothelial Cancer ◽

Phase 2 ◽

Preliminary Results ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Cancer

Download Full-text

Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status

European Urology Oncology ◽

10.1016/j.euo.2020.02.009 ◽

2020 ◽

Vol 3 (3) ◽

pp. 351-359

Author(s):

Petros Grivas ◽

Elizabeth R. Plimack ◽

Arjun V. Balar ◽

Daniel Castellano ◽

Peter H. O’Donnell ◽

...

Keyword(s):

Older Patients ◽

Urothelial Cancer ◽

Performance Status ◽

First Line Therapy ◽

Line Therapy ◽

Advanced Urothelial Cancer ◽

And Performance

Download Full-text

Pembrolizumab (pembro) as first-line therapy in elderly patients (pts) with poor performance status with cisplatin-ineligible advanced urothelial cancer (UC): Results from Keynote-052

European Urology Supplements ◽

10.1016/s1569-9056(18)30938-2 ◽

2018 ◽

Vol 17 (2) ◽

pp. e124-e125 ◽

Author(s):

D. Castellano ◽

P. Grivas ◽

E. Plimack ◽

A. Balar ◽

P. O’Donnell ◽

...

Keyword(s):

Elderly Patients ◽

Urothelial Cancer ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

First Line Therapy ◽

Line Therapy ◽

Advanced Urothelial Cancer

Download Full-text

The weekly triplet: Gemcitabine, carboplatine and paclitaxel as first line therapy for advanced urothelial cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4704 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4704-4704 ◽

Author(s):

G. Y. Chahine ◽

J. G. Kattan ◽

F. S. Farhat ◽

F. L. Nasr ◽

W. T. Moukaddem ◽

...

Keyword(s):

Urothelial Cancer ◽

First Line Therapy ◽

Line Therapy ◽

Advanced Urothelial Cancer

Download Full-text